The global microcrystalline cellulose (MCC) market is driven by its widespread use as an excipient in pharmaceuticals, as well as applications in food, cosmetics, and other industries [1][2]. MCC functions as a binder, disintegrant, filler, and flow aid in tablet manufacturing [3]. Its increasing demand in the pharmaceutical sector, particularly for solid dosage forms, is a key market driver [1].
What makes MCC so useful in pharmaceuticals?
Microcrystalline cellulose is favored in pharmaceuticals due to its inertness, excellent compressibility, and ability to improve tablet hardness and disintegration [3]. It is derived from highly purified wood pulp and is a versatile excipient used in over 60% of all solid oral dosage forms [4]. Its physical properties allow for efficient processing and consistent drug delivery [3].
How is MCC used in the food industry?
In the food industry, MCC serves as a fat substitute, thickener, anti-caking agent, and stabilizer [2]. It is also used as a low-calorie filler and emulsifier, contributing to product texture and stability [5].
What are the different types of MCC available?
MCC is available in various grades, differing in particle size, density, and moisture content, allowing manufacturers to select the optimal grade for specific applications [3]. These variations influence its performance as a binder and disintegrant [4].
Are there concerns about the safety of MCC?
Microcrystalline cellulose is generally recognized as safe (GRAS) by regulatory bodies like the U.S. Food and Drug Administration (FDA) and is approved for use in food and pharmaceuticals worldwide [1][6]. It is non-toxic and non-habit forming [4].
Who are the main manufacturers of MCC?
Key players in the microcrystalline cellulose market include DuPont, JRS Pharma, Asahi Kasei, and RAMA Paper & Industries [1]. These companies supply MCC globally for various industrial and pharmaceutical needs.